Sandip Vasavada, MD

216.444.5600

Sandip Vasavada, MD

Appointed: 2001

Sandip Vasavada, MD
Department: Urology
Location: Cleveland Clinic Main Campus
Mail Code Q10-1
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.5600
DeskDesk:216.445.0296
WorkFax:216.445.7031
Sandip Vasavada, MD
Department: Urology
Location: Richard E. Jacobs Health Center
Mail Code Q10-1
33100 Cleveland Clinic Blvd.
Avon, OH 44011
WorkAppointment:216.444.5600
DeskDesk:216.445.0296
WorkFax:216.445.7031
Sandip Vasavada, MD
Department: Obstetrics and Gynecology
Location: Cleveland Clinic Main Campus
Mail Code Q10-1
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.5600
DeskDesk:216.445.0296
WorkFax:216.445.7031
Surgeon:
Yes
Treats:
Adults Only

Biographical Sketch

Sandip Vasavada, MD, serves as the Urologic Director, Center for Female Urology and Reconstructive Pelvic Surgery, at Cleveland Clinic within the Glickman Urological Institute. Together with his other colleagues he helps represent one of the largest centers for female urology and reconstructive genitourinary surgery in the country. He is also Associate Professor of Surgery (Urology) at the Cleveland Clinic Lerner College of Medicine and has a joint appointment with the Women's Institute.

Dr. Vasavada completed his medical school training in the competitive six-year combined BS/MD program at Northeastern Ohio Universities College of Medicine in 1991. Upon graduation, he began his urology residency at Cleveland Clinic and graduated the residency in 1997. Subsequently, he began a fellowship in female urology, neuro-urology and reconstruction at the UCLA School of Medicine in Los Angeles, Calif. He then took a position as Assistant Professor of Urology at Thomas Jefferson Medical College in Philadelphia prior to returning to Cleveland in 2001.

Dr. Vasavada has published numerous manuscripts and book chapters in the area of voiding dysfunction and urinary incontinence and has been named to "Top Docs" in Philadelphia and Cleveland magazines for the past several years. He has published two textbooks, the first entitled Female Urology, Urogynecology and Voiding Dysfunction (Marcel-Dekker, N.Y., 2005) and his second book on Female Urology and Pelvic Organ Prolapse with co-author Howard Goldman, MD (Humana Publishing, 2007) and is in the midst of completing his third textbook. He has authored over 70 manuscripts and over 25 book chapters and numerous abstracts and videos and has lectured and demonstrated surgical techniques around the world. Dr Vasavada is a reviewer for seven major journals in the field of urology and/or voiding dysfunction.

Dr. Vasavada's main clinical interests lie in the area of urinary incontinence, pelvic organ prolapse and complex reconstruction of the lower urinary tract and management of complications of vaginal and lower urinary tract surgery. His current research interests are in the field of refractory bladder overactivity and neuromodulation and care pathways for optimizing care in patients undergoing incontinence and prolapse surgery. Dr. Vasavada serves with the Section of Urogynecology on the NIH-Pelvic Floor Disorders Network.

Professional Highlights

  • Executive Council, Society for Female Urology and Urodynamics
  • Society of Female Urology and Urodynamics
  • International Continence Society
  • American Urogynecologic Society
  • American Urological Association
  • Executive Council Indian Urological Association

Education & Fellowships

Fellowship - University of California Los Angeles Medical Center
female urology incontinence voiding dysfunctions
Los Angeles, CA USA
1999
Residency - Cleveland Clinic
Urology
Cleveland, OH USA
1997
Internship - Cleveland Clinic
General Surgery
Cleveland, OH USA
1992
Medical School - Northeastern Ohio Universities College of Medicine
Rootstown, OH USA
1991
Undergraduate - University of Akron
Akron, OH USA
1987

Certifications

  • Urology

Specialty Interests

Complex pelvic reconstruction, complications of vaginal surgery, female urology, male incontinence, neuromodulation, prolapse, prolapse surgery, urethrovaginal reconstruction, urinary incontinence, neuromodulation

Awards & Honors

  • Top Docs, Cleveland magazine, 2006, 2007, 2008, 2009, 2010, 2011 
  • Teacher of the Year, 2010
  • Top 40 Under 40, Crain's Business, 2006
  • America's Top Physicians, 2005
  • Innovator Award, Cleveland Clinic Innovations, 2004
  • Clinical Patient Satisfaction Award, Cleveland Clinic Westlake, 2004
  • Best Doctors in America, 2002-Present
  • Top Docs in Women's Health, Philadelphia magazine, 2000
  • Second Place, "Gold Journal," Pediatric Urology Essay Contest, 1998
  • International Traveling Fellowship Award ; Meritorious Performance, 1997
  • George and Grace Crile Fellowship Award ; Surgical Excellence, 1997
  • First Place, Cleveland Urologic Society Resident Essay Contest, 1995
  • Alpha Omega Alpha Honor Society Research Award, 1991

Memberships

  • American Urological Association
  • Society for Female Urology and Urodynamics
  • Indian American Urological Association
  • Endourological Society
  • International Continence Society

Treatment & Services

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 11/20/2013, Dr. Vasavada has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Vasavada received fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Medtronic, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
Cleveland Clinic Mobile Site